AI주식인사이트AI Stock Insight
C

SCL사이언스

246960KOSDAQ의료용품 및 기타 의약 관련제품 제조업

47.1 / 100

Reference Date: 2026-06-10

Financial Score13.5 / 40
News Sentiment20.6 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 9.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SCL Science is a company specializing in protein-based platform technologies, offering hemostatic products, bio-logging services, and healthcare data platforms. In 2025, its consolidated sales reached 22,011 million KRW, reflecting a 365% increase driven by growth in bio-logging and data platform services. Key products include the 'InnoSEAL' hemostatic series, 'InTro' catheters, and AI-powered medical data solutions, with expansion into high-risk medical device markets and global bio-logging services.

Number of Employees

163people

Average Salary

77.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 19.194.0Point
PBR
2.55Industry Average 1.301.0Point

2.0x industry avg (risky)

ROE
-21.12Industry Average -4.893.5Point

4.3x industry avg (excellent)

Debt Ratio
134.87Industry Average 6.860.0Point

19.7x industry avg (risky)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲311.5% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲8.0% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -24.7% (improving, 3yr)

Detailed News Sentiment

11 totalPositive 10Neutral 1Negative 0Average Sentiment Score 82.3

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 1,760Won52-week high 4,04052-week low 1,672
1-month return1.0Point

1m -9.47% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27
  • Neutral분기보고서 (2026.03)2026-05-15
  • Neutral[기재정정]사업보고서 (2025.12)2026-05-15